Matches in SemOpenAlex for { <https://semopenalex.org/work/W4280613612> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- W4280613612 endingPage "233" @default.
- W4280613612 startingPage "226" @default.
- W4280613612 abstract "Atypical hemolytic-uremic syndrome (aHUS) is an orphan disease characterized by the development of thrombotic microdgium due to uncontrolled activation of the alternative complement pathway. Mutations of factors preventing excessive activation of the complement system are detected in most patients. For many years, despite the lack of appropriate evidence-based indications, plasmotherapy (PT) remained the first line treatment method. However, approaches to the management of patients have changed significantly with the accumulation of numerous data on the rapid progression to the end-stage renal disease regardless of whether PT was carried out initially or not. Statistical data has changed significantly with the launch of pathogenetic anticomplement therapy with monoclonal antibody (mAb) eculizumab due to most patients achieving remission of TMA and normalization of renal functions. The article presents a clinical case of a child with typical features of nephrotic syndrome with an early onset of disease. A heterozygous mutation in the CFH gene that was detected initially did not cause concerns about possible aHUS due to the lack of laboratory and morphological data for TMA. However, subsequently, the episodes of acute renal injury in combination with thrombotic microangiopathy (TMA) and severe arterial hypertension developed in a child, which made it possible to reconsider the diagnosis of aHUS and initiate the therapy with the biological analogue of eculizumab of a Russian origin, in which remission of TMA and complete recovery of renal functions were achieved. This clinical case demonstrates the difficulties of differential diagnosis of congenital nephropathies. Prognostic adverse outcomes in aHUS require a thorough evaluation of data with early induction of specific biological therapy, which allows the successful monitoring of the course of the disease." @default.
- W4280613612 created "2022-05-22" @default.
- W4280613612 creator A5007890353 @default.
- W4280613612 creator A5011360839 @default.
- W4280613612 creator A5012716905 @default.
- W4280613612 creator A5012840128 @default.
- W4280613612 creator A5019892286 @default.
- W4280613612 creator A5034864713 @default.
- W4280613612 creator A5060776141 @default.
- W4280613612 creator A5084319963 @default.
- W4280613612 creator A5085229574 @default.
- W4280613612 creator A5085349936 @default.
- W4280613612 date "2022-06-17" @default.
- W4280613612 modified "2023-09-26" @default.
- W4280613612 title "SUCCESSFUL USE OF ECULIZUMAB IN THE UNUSUAL COURSE OF ATYPICAL HEMOLYTIC-UREMIC SYNDROME IN A CHILD" @default.
- W4280613612 doi "https://doi.org/10.24110/0031-403x-2022-101-3-226-233" @default.
- W4280613612 hasPublicationYear "2022" @default.
- W4280613612 type Work @default.
- W4280613612 citedByCount "0" @default.
- W4280613612 crossrefType "journal-article" @default.
- W4280613612 hasAuthorship W4280613612A5007890353 @default.
- W4280613612 hasAuthorship W4280613612A5011360839 @default.
- W4280613612 hasAuthorship W4280613612A5012716905 @default.
- W4280613612 hasAuthorship W4280613612A5012840128 @default.
- W4280613612 hasAuthorship W4280613612A5019892286 @default.
- W4280613612 hasAuthorship W4280613612A5034864713 @default.
- W4280613612 hasAuthorship W4280613612A5060776141 @default.
- W4280613612 hasAuthorship W4280613612A5084319963 @default.
- W4280613612 hasAuthorship W4280613612A5085229574 @default.
- W4280613612 hasAuthorship W4280613612A5085349936 @default.
- W4280613612 hasConcept C111684460 @default.
- W4280613612 hasConcept C126322002 @default.
- W4280613612 hasConcept C159654299 @default.
- W4280613612 hasConcept C203014093 @default.
- W4280613612 hasConcept C2777637130 @default.
- W4280613612 hasConcept C2777878052 @default.
- W4280613612 hasConcept C2777991916 @default.
- W4280613612 hasConcept C2778930706 @default.
- W4280613612 hasConcept C2779134260 @default.
- W4280613612 hasConcept C71924100 @default.
- W4280613612 hasConcept C90924648 @default.
- W4280613612 hasConceptScore W4280613612C111684460 @default.
- W4280613612 hasConceptScore W4280613612C126322002 @default.
- W4280613612 hasConceptScore W4280613612C159654299 @default.
- W4280613612 hasConceptScore W4280613612C203014093 @default.
- W4280613612 hasConceptScore W4280613612C2777637130 @default.
- W4280613612 hasConceptScore W4280613612C2777878052 @default.
- W4280613612 hasConceptScore W4280613612C2777991916 @default.
- W4280613612 hasConceptScore W4280613612C2778930706 @default.
- W4280613612 hasConceptScore W4280613612C2779134260 @default.
- W4280613612 hasConceptScore W4280613612C71924100 @default.
- W4280613612 hasConceptScore W4280613612C90924648 @default.
- W4280613612 hasIssue "3" @default.
- W4280613612 hasLocation W42806136121 @default.
- W4280613612 hasOpenAccess W4280613612 @default.
- W4280613612 hasPrimaryLocation W42806136121 @default.
- W4280613612 hasRelatedWork W2024870615 @default.
- W4280613612 hasRelatedWork W2034286783 @default.
- W4280613612 hasRelatedWork W2077986770 @default.
- W4280613612 hasRelatedWork W2128719952 @default.
- W4280613612 hasRelatedWork W2140370443 @default.
- W4280613612 hasRelatedWork W2141534367 @default.
- W4280613612 hasRelatedWork W2259036662 @default.
- W4280613612 hasRelatedWork W2904881915 @default.
- W4280613612 hasRelatedWork W2972154622 @default.
- W4280613612 hasRelatedWork W2997675070 @default.
- W4280613612 hasVolume "101" @default.
- W4280613612 isParatext "false" @default.
- W4280613612 isRetracted "false" @default.
- W4280613612 workType "article" @default.